On December 12, Tom Lee, Fundstrat Global Advisors managing partner and head of research, joined CNBC's 'Closing Bell' to discuss his playbook for 2025.
Keep Reading →
December 22 - Hedge Funds, News
Investors have long been drawn to dividend stocks due to their financial stability and impressive returns, which have consistently outperformed other asset classes over the years...
Keep Reading →
December 20 - Dividend Stocks, Hedge Funds, News
The stock market appears poised for another year of impressive returns, likely extending into 2025. However, concerns about high valuations persist.
Keep Reading →
December 19 - Hedge Funds, News
As the Federal Reserve exits the year by having continued its interest rate cuts, Wall Street is wondering what 2025 will hold for markets.
Keep Reading →
December 18 - News
Most people have at some point sought to include weight loss and physical exercise in their daily life.
Keep Reading →
December 14 - Hedge Funds, News
Pfizer just raised its dividend by 2.4% to $0.43, giving investors something to cheer about despite the stock’s lackluster performance lately.
Keep Reading →
December 14 - News, Stock Analysis
The US economy expanded by 2.8% in the third quarter of 2024, as reported in the Advance GDP release from the U.S. Bureau of Economic Analysis.
Keep Reading →
December 10 - Dividend Stocks, Hedge Funds, News
There has been a growing debate regarding whether the economy of the United States will have a soft landing.
Keep Reading →
December 5 - Hedge Funds, News
A decade ago, the cannabis industry was in full swing as stock valuations exploded to record highs in states across the country legalizing pot use for medicinal and recreational...
Keep Reading →
November 27 - Hedge Funds, News
On Thursday, Jim Cramer, host of Mad Money, discussed the current state of the market following the election, noting that it has been marked by extreme volatility, with some sectors...
Keep Reading →
November 18 - Hedge Funds, News
The global immunotherapy drugs market is rapidly expanding, with projections to grow from $240 billion in 2023 to $1.3 trillion by 2033.
Keep Reading →
November 18 - Hedge Funds, News
Dividend stocks have long been favored by investors for the income they generate, and they become even more appealing when dividends increase over time.
Keep Reading →
November 12 - Dividend Stocks, Hedge Funds, News
The first week of November has been quite eventful so far.
Keep Reading →
November 8 - Hedge Funds, News
Healthcare takes the concept of 'defensive' further than almost any industry, encompassing many companies that provide patient care, engage in the research and development of ...
Keep Reading →
November 4 - Hedge Funds, Industries, News
Operator: Good day, everyone, and welcome to Pfizer's Third Quarter 2024 Earnings Conference Call. Today's call is being recorded.
Keep Reading →
October 31 - News, Transcripts
The third quarter ended with a bang, with all the major indices near record highs as investors shunned macroeconomic instability, soaring geopolitical tensions and U.S.
Keep Reading →
October 20 - Hedge Funds, News
On October 14, Tom Lee, Fundstrat Global Advisors managing partner and head of research, appeared in an interview on CNBC to discuss the latest market trends and share his expectations...
Keep Reading →
October 14 - Hedge Funds, News
As the fourth quarter of 2024 settles in, the narrative surrounding stocks on Wall Street is starting to shift.
Keep Reading →
October 12 - News
The economic impact of AI is projected to be substantial, particularly in regions like China and North America, which are expected to see GDP boosts of 26% and 14.5%, respectively...
Keep Reading →
October 5 - Hedge Funds, Industries, News, Tech
A lot has happened in the stock market during the last couple of weeks. The Fed cut rates by 50 basis points to help the weakening labor market.
Keep Reading →
September 29 - Hedge Funds, News
The CNBC host said that he has reminded his viewers repeatedly that when the Fed is your “enemy” you should stick to recession-proof stocks that can produce consistent earnings...
Keep Reading →
September 28 - Hedge Funds, News
On September 23, Chris Watling, Longview Economics founder, CEO, and chief market strategist, appeared in an interview on Yahoo Finance to discuss the rate easing path and the...
Keep Reading →
September 28 - Hedge Funds, News
As we navigate through 2024, the economic landscape presents a mix of challenges and opportunities for investors.
Keep Reading →
September 28 - Hedge Funds, News
The CNBC host said that he has reminded his viewers repeatedly that when the Fed is your “enemy” you should stick to recession-proof stocks that can produce consistent earnings...
Keep Reading →
September 27 - Hedge Funds, News
Investing in healthcare equities is typically seen as protective during difficult economic times.
Keep Reading →
September 27 - News, Stock Analysis
Undoubtedly, global and domestic investors have mastered the art of riding out the highs and lows of the US stock market.
Keep Reading →
September 22 - Hedge Funds, News
In a recent episode of Mad Money, Jim Cramer traveled to Dreamforce to understand the true capabilities of artificial intelligence (AI) and to separate fact from hype.
Keep Reading →
September 19 - Hedge Funds, News
Innovation plays a crucial role in today's market.
Keep Reading →
September 18 - Dividend Stocks, Hedge Funds, News
The Fed plans to initiate rate cuts for the first time in over four years and investors do not know what to expect of the financial markets moving forward.
Keep Reading →
September 18 - Hedge Funds, News
With rising costs in today's world, people are constantly searching for ways to earn additional income. To do this, many rely on side hustles to make ends meet.
Keep Reading →
September 16 - Dividend Stocks, Hedge Funds, News
We came across a bullish thesis on Pfizer Inc. (PFE) on gurufocus by Akim Guerreiro. In this article we will summarize the bulls’ thesis on PFE. Pfizer Inc.
Keep Reading →
September 13 - News, Stock Analysis
September and October tend to be the most volatile months for the stock market, particularly during election years.
Keep Reading →
September 7 - Hedge Funds, News
Dividend stocks have faced challenges over the past year due to the rising focus on tech stocks.
Keep Reading →
September 4 - Dividend Stocks, Hedge Funds, News
In 2022, the global oncology market was valued at approximately $203.42 billion and is expected to reach over $470.61 billion by 2032, growing at a compound annual growth rate...
Keep Reading →
August 31 - Hedge Funds, Industries, News
Several traders tend to profit from stocks through appreciation. However, some do the opposite-- their idea is to profit from stocks when their value declines.
Keep Reading →
August 27 - Hedge Funds, News
The bullish market trend that had been ongoing since October 2022 faced a disruption in early August. Investor sentiment shifted as concerns about the U.S.
Keep Reading →
August 18 - Dividend Stocks, Hedge Funds, News
Operator: Good day, everyone, and welcome to Pfizer's Second Quarter 2024 Earnings Conference Call. Today's call is being recorded.
Keep Reading →
July 31 - News, Transcripts
Retail investors often discuss their investments on platforms such as Reddit and have become a major market force in recent years.
Keep Reading →
July 21 - News
Parnassus Investments, an investment management company, released the “Parnassus Value Equity Fund” first quarter 2024 investor letter.
Keep Reading →
July 1 - Hedge Fund Investor Letters, News
This article looks at the 10 best healthcare stocks to buy under $50.
Keep Reading →
June 26 - News
In this article, we are going to discuss the 10 best healthcare stocks to buy according to hedge funds.
Keep Reading →
June 24 - Hedge Funds, News
Diamond Hill Capital, an investment management company, released its “Select Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
June 11 - Hedge Fund Investor Letters, News
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Pfizer Inc.
Keep Reading →
June 3 - Hedge Funds, News, Stock Analysis
In this article, we will be discussing the best gene therapy stocks to buy now. Before we move on to our list, let's take a look at the market outlook for gene therapies and ...
Keep Reading →
June 3 - Hedge Funds, News, Stock Analysis
This article presents an overview of Jim Cramer is Recommending These 5 Stocks. For a detailed overview of such stocks read our article, Jim Cramer is Recommending These...
Keep Reading →
May 22 - Hedge Funds, News
Dividend stocks are gaining traction among seasoned as well as retail investors this year. The addition of some of the biggest tech names, such as Meta Platforms, Inc.
Keep Reading →
May 20 - Dividend Stocks, Hedge Funds, News
In this article, we discuss the 5 best affordable stocks under $40.
Keep Reading →
May 14 - Hedge Funds, News
In this article, we will discuss 5 dividend growth stocks with over 3% yield.
Keep Reading →
May 13 - Dividend Stocks, Hedge Funds, News
In this article, we discuss 15 best S&P 500 dividend stocks to buy now.
Keep Reading →
May 7 - Dividend Stocks, Hedge Funds, News
Pfizer Inc. beats earnings expectations. Reported EPS is $0.82, expectations were $0.516. Pfizer Inc.
Keep Reading →
May 2 - News, Transcripts